{"id":"W4410785948","doi":"10.1038/s41591-025-03704-9","title":"Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Health and Medical Research Council; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Michael Smith Health Research BC; Prostate Cancer Foundation","keywords":"Cabazitaxel; Lutetium; Medicine; Prostate cancer; Prostate; Oncology; Cancer research; Cancer; Internal medicine; Pharmacology; Chemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00249829,0.001183726,0.001794541,0.0004607003,0.0003695077,0.0009374561,0.0006582042,0.001434561,0.005399873],"category_scores_gemma":[0.002210142,0.0005207535,0.001346947,0.0005266352,0.001097675,0.0009961578,0.0003574063,0.002069627,0.0007970933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001195943,"about_ca_system_score_gemma":0.00196344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084764,"about_ca_topic_score_gemma":0.003021793,"domain_scores_codex":[0.9986713,0.000905584,0.00003606703,0.0001572035,0.00009299623,0.000136935],"domain_scores_gemma":[0.9989053,0.0003918149,0.0002127949,0.0001200873,0.00005226608,0.0003177458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9419823,0.003862189,0.003170419,0.0002241076,0.001181651,0.00005928849,0.00006429858,0.0009670121,0.009690333,0.0003178261,0.001861647,0.03661881],"study_design_scores_gemma":[0.8804644,0.1036335,0.008387196,0.0000341571,0.001178344,0.0001266,0.00003816261,0.001057406,0.002226375,0.0006130491,0.00220788,0.00003282452],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912798,0.002506547,0.0005748294,0.001207527,0.0001805961,0.0008950833,0.001448673,0.00009408205,0.001812811],"genre_scores_gemma":[0.9881643,0.001382956,0.001842221,0.001117486,0.000262914,0.001618703,0.002640775,0.00005684521,0.002913732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005399873,"threshold_uncertainty_score":0.01806438,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02543317374760138,"score_gpt":0.4158875125835805,"score_spread":0.3904543388359791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}